Atara Biotherapeutic Inc. has appointed Utpal Koppikar as chief financial officer.
Apollo Medical Holdings Inc. has appointed Eric Chin as chief financial officer. He will succeed the current CFO, Mihir Shah, effective July 1.
Pegi Matsuda, a longtime civic leader in the San Fernando Valley, has sent an email saying she will step down from her position at Valley Presbyterian Hospital.
Mylan NV has received U.S. Food and Drug Administration approval to market its biosimilar of Amgen Inc.’s drug Neulasta.
The Food and Drug Administration has denied Amgen’s application for a biosimilar of Roche’s breast cancer drug Herceptin.
Several of Amgen Inc.’s early-stage therapies for lung and blood cancers will be available to patients through trials at the University of Texas MD Anderson Cancer Center in Houston as part of a five-year collaboration between the Thousand Oaks company and the cancer hospital.
The Amgen Foundation has partnered with Harvard University to launch a free online science education platform for high schoolers and college students, the Thousand Oaks biotechnology company announced Wednesday.
RETAIL: Tarzana customers seek relief from inflammation, pain.
Amgen Inc. has partnered with four government agencies and universities to launch a program aimed at helping cancer patients better manage their symptoms.
About 100 employees of Providence Tarzana Medical Center turned out for a picket yesterday to protest what they described as unfair labor practices.
Five people were arrested and charged on Tuesday with conducting a health insurance fraud scheme that involved patients at a pair of medical spas in the San Fernando Valley.
A nearly half-century old cancer registry managed by USC has received nearly $44 million to track the disease in Los Angeles County for the next 10 years, the university announced Monday.
Amgen Inc.’s drug Aimovig has received Food and Drug Administration approval for the prevention of migraines in adults, the first drug of its kind to do so.
The Food and Drug Administration has approved Pfizer’s application for Retacrit, a biosimilar of Amgen Inc. and Johnson & Johnson’s anemia drug Epogen.
Adventist Health has appointed Alice Issai as president of Adventist Health Glendale, the hospital system announced Monday.